Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04487301 · ClinicalTrials.gov registry record
A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease
A clinical trial of Peripheral Artery Disease and End Stage Renal Disease on Dialysis, sponsored by Sanifit Therapeutics S. A..
- Completed
- Registry status
- 36
- Enrollment target
- 7
- Study locations
NCT04487301 is a study of Peripheral Artery Disease and End Stage Renal Disease on Dialysis that has completed, run by Sanifit Therapeutics S. A.. The registered enrollment target is 36 participants, below the 126-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (71% lower). The trial reports 7 study locations across 6 states.
The verdict
NCT04487301, a study of Peripheral Artery Disease and End Stage Renal Disease on Dialysis, has completed, sponsored by Sanifit Therapeutics S. A..
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
- 7
- Study locations
Study Summary
A cross-sectional, non-interventional study to assess walking performance, vascular function, and lower limb calcification in subjects with peripheral artery disease and end-stage kidney disease (PAD-ESKD) receiving hemodialysis.
Conditions Studied
Study Locations (7)
Massachusetts
- Brigham and Women's Hospital - Boston
- Boston Medical Center - Boston
California
- Valley Renal Medical Group - Northridge
Florida
- Horizon Medical Research - Coral Gables
Missouri
- St Louis Kidney Care - St Louis
North Carolina
- Mountain Kidney & Hypertension Associates - Asheville
Texas
- Houston Medical Research - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2020-11-16 |
| Est. Completion | 2021-06-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04487301
The ClinicalTrials.gov registry entry for NCT04487301 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 126-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (71% lower). The listed sponsor is Sanifit Therapeutics S. A., which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Peripheral Artery Disease appearing as the primary indexed condition, and to 0 interventions.
NCT04487301 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Massachusetts, California, Florida.
Frequently Asked Questions
What is clinical trial NCT04487301 about?
NCT04487301 is a clinical study titled "A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease". A cross-sectional, non-interventional study to assess walking performance, vascular function, and lower limb calcification in subjects with peripheral artery disease and end-stage kidney disease (PAD-ESKD) receiving hemodialysis.
What is the current status of trial NCT04487301?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2020-11-16. Estimated completion is 2021-06-12.
What conditions does trial NCT04487301 study?
This clinical trial studies the following conditions: Peripheral Artery Disease, End Stage Renal Disease on Dialysis.
Who is sponsoring clinical trial NCT04487301?
This trial is sponsored by Sanifit Therapeutics S. A., which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04487301 being conducted?
This trial has 7 study locations across California, Florida, Massachusetts, Missouri, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Response to Exercise and Nitric Oxide in PAD
RECRUITING · Phase 2
-
The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication
RECRUITING · Phase 1
-
Improving Mobility After Revascularization in Peripheral Artery Disease
RECRUITING · Phase 3
-
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
RECRUITING · NA
-
BEETroot Juice to Reverse Functional Impairment in PAD
RECRUITING · NA
-
Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
RECRUITING · NA
Explore more on PlainTrial
Peripheral Artery Disease
All registered trials for this condition
End Stage Renal Disease on Dialysis
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.